Related Experiment Video
Updated: Apr 21, 2026
15:12
Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae
Published on: May 10, 2014
14.7K
Cystinosis: clinical presentation, pathogenesis and treatment
Pediatric Endocrinology Reviews : PER
|October 28, 2014
Summary
Nephropathic cystinosis, a rare genetic disorder, causes cystine buildup, leading to kidney damage. Current treatments manage symptoms but don't cure Fanconi syndrome, necessitating further therapeutic research.
Area of Science:
- Genetics
- Cell Biology
- Rare Diseases
Background:
- Nephropathic cystinosis is a rare lysosomal storage disorder.
- Caused by CTNS gene mutations, leading to cystine accumulation in lysosomes.
- Results in cellular dysfunction, including endocytosis and cell signaling deregulation.
Purpose of the Study:
- To review the current understanding of nephropathic cystinosis.
- To discuss current therapeutic strategies and their limitations.
- To highlight emerging therapeutic approaches for cystinosis.
Main Methods:
- Literature review of nephropathic cystinosis.
- Analysis of current cystine-lowering therapies.
- Exploration of novel therapeutic avenues like stem cell and gene therapy.
Main Results:
- Cystinosin deficiency causes widespread cystine accumulation and cellular dysfunction.
- Fanconi syndrome is an early renal manifestation.
- Cysteamine therapy slows progression but doesn't cure Fanconi syndrome.
Conclusions:
- Further therapeutic development beyond cysteamine is crucial for nephropathic cystinosis.
- Investigating cell signaling and exploring stem cell/gene therapy show promise.
- Addressing Fanconi syndrome and offering a cure remain key goals.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
699
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
9.9K
Related Concept Videos
01:23Cystic Fibrosis: Pathogenesis
1.1K
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
01:24Cystic Fibrosis: Management
645
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
645
01:28Urinary Tract Calculi I: Introduction
1.0K
Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
1.0K
01:20Inborn Errors of Metabolism
1.0K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
01:22Lysosomal Hydrolases
3.5K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K
01:26Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
789
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
789